
OSAKA -- Japanese Nobel laureate Tasuku Honjo and drugmaker Ono Pharmaceutical reached a settlement on Friday in a lawsuit over the distribution of patent royalties related to cancer immunotherapy Opdivo.
Settlement to go as donation to Kyoto University, where Tasuku Honjo is professor
OSAKA -- Japanese Nobel laureate Tasuku Honjo and drugmaker Ono Pharmaceutical reached a settlement on Friday in a lawsuit over the distribution of patent royalties related to cancer immunotherapy Opdivo.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.